Order

Size
Price
Stock
Qty

NMS-1286937

 - Onvansertib  - NMS-P 937
Axon 4007
CAS:  1034616-18-6
Purity:  99%
  • Soluble in DMSO
  • MF:  C24H27F3N8O3
  • MW:  532.52

Description

NMS1286937 is an orally bioavailable, small-molecule Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity. NMS-1286937 selectively and effectively inhibits PLK1 (with IC50 at low nM), inducing selective G2/M cell-cycle arrest followed by apoptosis in a variety of tumor cells while causing reversible cell-cycle arrest at the G1 and G2 stages without apoptosis in normal cells.

More Information

Parent CAS No. 1034616-18-6
Chemical Name 1-(2-Hydroxyethyl)-8-(5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
extra_info Sold in collaboration with Chemietek
SMILES C1(NC2C(OC(F)(F)F)=CC=C(N3CCN(C)CC3)C=2)N=C2C3N(CCO)N=C(C(N)=O)C=3CCC2=CN=1
MFCD N.A.
InChi InChI=1S/C24H27F3N8O3/c1-33-6-8-34(9-7-33)15-3-5-18(38-24(25,26)27)17(12-15)30-23-29-13-14-2-4-16-20(22(28)37)32-35(10-11-36)21(16)19(14)31-23/h3,5,12-13,36H,2,4,6-11H2,1H3,(H2,28,37)(H,29,30,31)
InChiKey QHLVBNKYJGBCQJ-UHFFFAOYSA-N
CID 49792852
Short Description PLK1 inhibitor

Related Products

AXON ID NAME FROM PRICE
1129 BI 2536

From $99.00

1131 GW 843682X

From $93.50

1473 BI 6727

From $99.00

1625 GSK579289A

From $121.00

1626 GSK 461364 analogue II

From $143.00

1688 GSK 461364

From $115.50

1910 MLN0905

From $104.50

2358 Mps1-IN-2

From $104.50

2950 Rigosertib sodium

From $104.50

3918 CZS-241 hydrochloride

From $176.00

4192 (S)-BI 2536

From $187.00

Loading...